A preliminary U.S. Supreme Court order on Friday, April 21, preserves the U.S. Food and Drug Administration’s two-decade-old approval of the abortion pill mifepristone until the full merits of the case are heard by the high court.
A preliminary U.S. Supreme Court order on Friday, April 21, preserves the U.S. Food and Drug Administration’s two-decade-old approval of the abortion pill mifepristone until the full merits of the case are heard by the high court.
